Jerash Holdings (US) JRSH 深 沪
已收盘 08-29 16:00:00 美东时间
3.4085
+0.009
+0.25%
华盛通- 最 高3.4294
- 今 开3.4243
- 成交量 1.19万股
- 最 低 3.375
- 昨 收 3.40
- 总市值 4190.68万
- 52周最高 4.02
- 市盈率 静 --
- 换手率 0.10%
- 52周最低 2.65
- 委 比 70.99%
- 总股本 1229.48万
- 历史最高 8.99
- 量 比 0.31
- 振 幅 1.60%
- 历史最低 2.42
- 每 手 1
- 风险率 0.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jerash Holdings Ends Joint Venture with Newtech
Jerash Holdings (US) ( ($JRSH) ) has shared an announcement. On August 20, 2025...
08-22 04:38
Jerash Holdings (US) Sees Q2 Sales $40.000M-$42.000M vs $40.450M Est
Jerash Holdings (US) (NASDAQ:JRSH) sees Q2 sales of $40.000 million-$42.000 million vs $40.450 million analyst estimate.
08-12 20:04
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
An Overview of Jerash Holdings (US)'s Earnings
Jerash Holdings (US) (NASDAQ:JRSH) will release its quarterly earnings report o...
08-12 01:03
Jerash Holdings declares $0.05 dividend
Jerash Holdings (NASDAQ:JRSH) declared $0.05/share quarterly dividend, in line with previous. Forward yield 6.08% Payable Aug. 29; for shareholders of record Aug. 22; ex-div Aug. 22. See JRSH Dividend...
08-08 20:18
美股大行评级 | 潜在涨幅312.09%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
潜在涨幅312.09%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级；联邦快递遭多家机构下调目标价>>
06-26 08:38
美股大行评级 | 潜在涨幅390.8%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
多家机构首予Amrize买入评级，目标价53~62美元；HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级>>
06-25 08:39
DA Davidson Maintains Buy on Jerash Holdings (US), Maintains $4 Price Target
DA Davidson analyst John Morris maintains Jerash Holdings (US) (NASDAQ:JRSH) with a Buy and maintains $4 price target.
06-25 01:38
Jerash Holdings Reports Record Revenue Growth
Jerash Holdings ( ($JRSH) ) has released its Q4 earnings. Here is a breakdown o...
06-24 11:52
Earnings Scheduled For June 23, 2025
Companies Reporting Before The Bell • Jerash Holdings (US) (NASDAQ:JRSH) is exp...
06-23 16:32
